6/9/25 We are currently making changes to reflect the new Health Sciences Division structure. Thank you for your patience.

Sign in
Spotlight commentary: Changes in pharmacokinetics following significant weight loss
Journal article   Open access   Peer reviewed

Spotlight commentary: Changes in pharmacokinetics following significant weight loss

Andrej Belančić and Hesham S. Al-Sallami
British journal of clinical pharmacology
15/01/2025
Handle:
https://hdl.handle.net/10523/44694

Abstract

History Missions missionary children Protestant missionary children GLP‐1 receptor agonists bariatric surgery drug dosage obesity pharmacokinetics weight loss
Obesity is associated with detrimental metabolic, mechanical and psychological outcomes, leading to diminished qualify of life and reduced lifespan. Whilst lifestyle modifications, including diet and physical activity, remain essential for managing obesity management, many patients with obesity require additional interventions for effective treatment. These include anti-obesity medicines (e.g., GLP-1 receptor agonists) and/or bariatric surgery.
pdf
Brit J Clinical Pharma - 2025 - Belančić - Spotlight commentary Changes in pharmacokinetics following significant weight312.58 kBDownloadView
Published (Version of record)CC BY-NC V4.0 Open Access
url
https://doi.org/10.1111/bcp.16401View
Published (Version of record)CC BY-NC V4.0 Open

Metrics

27 File views/ downloads
6 Record Views

Details

Logo image